Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04802304 · ClinicalTrials.gov registry record · NA

Beyond Bias - Reducing Provider Bias Towards Adolescents to Increase Contraception Take-Up in Tanzania, Burkina Faso, and Pakistan

A NA study, sponsored by RAND.

Completed
Registry status
NA
Development phase
233
Enrollment target

NCT04802304 is a NA study that has completed, run by RAND. The registered enrollment target is 233 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT04802304, a NA study, has completed, sponsored by RAND.

COMPLETED
Registry status
NA
Development phase
233 participants
Enrollment target

Study Summary

Beyond Bias will evaluate the impact of an intervention designed to reduce family planning provider bias towards young, unmarried, and nulliparous women in Tanzania, Burkina Faso, and Pakistan. The intervention has three components: 1) a summit that includes impactful stories told to and by family planning providers that highlight the consequences of provider bias, 2) a forum for continued communication between providers, and 3) a rewards program where clinics in which providers exhibit less biased client interactions or who have improved the most towards this end will be rewarded with social recognition and a ceremony. Half of the eligible clinics in each country (233 in total) are randomly assigned to receive the intervention, while the remaining half serves as control. The objective of the evaluation is to estimate the impact of the intervention on a range of outcomes related to quality of family planning care among young, unmarried, and nulliparous women. The investigators hypothesize that the intervention will increase the share of young, unmarried, and nulliparous women who received counseling on a range of methods, counseling on long acting methods, and who received their preferred method. The investigators will collect four types of data to evaluate the intervention: 1) provider surveys, 2) mystery clients' visits, 3) direct observations of client-provider interactions, and 4) qualitative interviews with clients, providers, and implementors.

Interventions

  • OTHER Beyond Bias Treatment

Trial Details

FieldValue
Enrollment Target 233 participants
Start Date 2020-09-01
Est. Completion 2022-10-14
Phase NA

Sponsor

RAND

78 total trials

What the Registry Record Tells You About NCT04802304

The ClinicalTrials.gov registry entry for NCT04802304 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 233 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is RAND, which has 78 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 1 intervention - of which Beyond Bias Treatment is the first listed.

NCT04802304 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT04802304 about?

NCT04802304 is a clinical study titled "Beyond Bias - Reducing Provider Bias Towards Adolescents to Increase Contraception Take-Up in Tanzania, Burkina Faso, and Pakistan". Beyond Bias will evaluate the impact of an intervention designed to reduce family planning provider bias towards young, unmarried, and nulliparous women in Tanzania, Burkina Faso, and Pakistan. The intervention has three components: 1) a summit that includes impactful stories told to and by family p...

What is the current status of trial NCT04802304?

This trial is currently completed. It is a NA study. The enrollment target is 233 participants. The study started on 2020-09-01. Estimated completion is 2022-10-14.

What interventions are being tested in trial NCT04802304?

The interventions under investigation include: Beyond Bias Treatment (OTHER).

Who is sponsoring clinical trial NCT04802304?

This trial is sponsored by RAND, which has 78 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.